BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases.
Millions worldwide are afflicted with genetic diseases, but small patient populations and industry reluctance to conduct early-stage development means that for many, treatments have not been forthcoming. We are committed to bridging this gap: between business case and scientific possibility, between patient and hope. BridgeBio creates a bridge from remarkable advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible.
BridgeBio is committed to developing leaders as well as drugs. We are looking for individuals whose passion for creating life-changing medicines will inspire hands-on engagement and the dogged pursuit of novel solutions in the face of adversity.
Company Details
- Employees
- 778
- Founded
- -
- Address
- 421 Kipling St, Palo Alto,california,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- bridgebiollc.com
- HQ
- Palo Alto, California
Bridgebio Questions
Bridgebio's website is bridgebiollc.com
Bridgebio's LinkedIn profile is https://www.linkedin.com/company/bridgebio
Bridgebio has
778 employees.
View email and phone details for 778
employees at Bridgebio.
Bridgebio's industry is
Biotechnology Research
Bridgebio's categories are Biotechnology Research
Bridgebio's founding year is 2014
